An open-ended equity scheme investing in healthcare and allied sectors.

Scheme details of Mirae Asset Healthcare Fund

Investment Objective of Mirae Asset Healthcare Fund*

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.

The Scheme does not guarantee or assure any returns.

*Source: Scheme Information Document

[Read: What You Should Read In A Scheme Information Document]

Is Mirae Asset Healthcare Fund for you?

Mirae Asset Healthcare Fund (MAHF) is an open-ended thematic fund which will predominantly invest in equity and equity related instruments of the companies belonging to healthcare sector.

Being a thematic fund around 80% - 100% of its net asset allocation will be inclined towards the healthcare sector. Hence, the portfolio construction will be focussed.

Thematic Funds invest in stocks from one particular common theme. They are growth-oriented equity schemes that aim at capital appreciation by investing in a set of say 3-4 sectors that are closely related to one particular theme.

For example, healthcare funds will invest in equities of pharmaceutical companies, Hospitals & Diagnostics, Medical Equipment and so on.

At present valuations of pharma sector are cheap and with the potential upside it is expected to bounce back in the future. Over the last few years, pharma industry has been hit due to various reasons such as rising competition, FDA inspections and so on.

Investing in thematic/ sector funds exposes you to portfolio concentration risk. Hence, MAHF is suitable for investors with high-risk appetite- meaning those who can assume very-high risk in an anticipation of high returns in future.

Asset Allocation of Mirae Asset Healthcare Fund

The asset allocation of Mirae Asset Healthcare Fund under normal circumstances will be as under:

Instruments	Indicative allocations (% of total assets)		Risk Profile High/Medium/Low
	Minimum	Maximum
Indian Equities and Equity Related Securities of companies that are likely to benefit either directly or indirectly from Healthcare and allied sectors.*	80	100	High
Other equities and equity related securities of companies in India.*	0	20	High
Money market instruments / debt securities, Instruments and/or units of debt/liquid schemes of domestic Mutual Funds	0	20	Low to Medium

*Equity and Equity related instruments include convertible debentures, equity warrants, convertible preference shares, equity derivatives etc. The Indian equities & equity related securities of companies includes those securities listed on stock exchanges in India and includes ADRs & GDRs.

Further it is stated in the offer document that:

• The scheme can invest up to 50% of Net Assets of Scheme into equity derivatives instruments for the purpose of trading, hedging and portfolio rebalancing.

• Investment in Securitized debt (excluding foreign securitized debt), if undertaken, would not exceed 20% of the net assets of the Scheme.

• The Scheme may invest in repo/reverse repo in corporate bonds.

• The scheme shall not engage in short selling, credit default swaps and securities lending and borrowing. The scheme shall not invest in any unrated debt instruments and derivatives. The scheme will not advance any loans. The scheme does not intend to invest in overseas / foreign securities. The Scheme does not intend to participate in stock lending.

(Source: Scheme Information Document)

Investment Strategy Of Mirae Asset Healthcare Fund

Being an open-ended thematic fund, the scheme will invest predominantly in equity and equity related instruments in the healthcare sector.

Equity Strategy

Being a healthcare fund, the fund manager will mainly focus on the healthcare sector.

The fund manager will analyse industry trends and business cycles in companies that benefit directly or indirectly from the Healthcare sector that may include companies from the Pharmaceutical, Healthcare, Hospitals & Diagnostics, Other Healthcare services, Research and/or Manufacturing Services, Distribution, Chemicals (Bulk, Specialty, Agrochemicals, Others), Medical Equipment, Insurance, Wellness, Nutrition, Hygiene, Health IT services, Financials and any other industry or services that directly or indirectly supports the pharma value chain.

Further, the fund may invest upto 20% of its net assets into equity and equity related securities of other companies.

It also has the flexibility to invest across market capitalization in portfolio companies within this theme. Moreover, the fund manager has the flexibility to follow a focussed approach for this theme. But the fund manager will try to have a large base of stocks in the portfolio to avoid concentration risk and liquidity risk.

To pick stocks and to build the equity portfolio, MAHF will majorly look at companies that have robust business models, enjoying sustainable competitive advantages as compared to their competitors and have high return ratios. The Fund Managers will also monitor the trading volumes in a particular stock before investment to avoid liquidity risk.

Debt Strategy

The fund while is mandated to invest around 0% - 20% of its net assets into debt and money market instruments, the investment team will primarily use a top-down approach for taking interest rate view, sector allocation along with a bottom up approach for security/instrument selection.

The bottom-up approach will assess the quality of debt security which will help in analyzing the the financial health of the issuer as well as the liquidity of the security.

As investments in debt instruments carry various risks such as interest rate risk, reinvestment risk, credit risk, liquidity risk and so on. The scheme aims to reduce this risk through diversification.

The credit quality of the debt portfolio will be maintained and monitored by MAHF using the fund house's in-house capabilities as well as inputs from external sources such as independent credit rating agencies.

Fund Managers for Mirae Asset Healthcare Fund

Mirae Asset Healthcare Fund will be jointly managed by Mr Vrijesh Kasera and Mr Neelesh Surana.

Mr Vrijesh Kasera has a professional experience of more than 10 years. He has an MBA (Finance), is a Chartered Financial Analyst (ICFAI), and holds a Master of Science in Finance from ICFAI University.

Prior to this assignment, he was associated with Axis Capital Ltd. as an Equity Research Analyst. Prior to joining Mirae Asset in 2016 he has also been associated with Edelweiss Broking Ltd.

Mr. Neelesh Surana is Head of Equities at Mirae Asset Global Investments (India) Pvt. Ltd.

Currently he is responsible for the managing existing equity funds of Mirae Asset (India), as well as, providing research support for the global mandate. He is an engineering graduate (B.E. –Mechanical) with MBA in Finance. He has over 18 years of experience in equity research and portfolio management.

Prior to Mirae, Mr Surana was associated with ASK Investment Managers Ltd., as Senior Portfolio Manager responsible for managing domestic and international portfolios.

Other Schemes managed by Mr Surana are Mirae Asset India Equity Fund, Mirae Asset Hybrid - Equity Fund, Mirae Asset Tax Saver Fund  and Mirae Asset Great Consumer Fund.

Fund Outlook of Mirae Asset Healthcare Fund

Being a thematic fund, MAHF will assume very high risk. The fortune of the fund will be closely linked to the overall performance of the healthcare sector.

On evaluating the fund's objective and investment strategy, MAHF will have upto 100% exposure to equity and equity related instruments of companies that are likely to benefit either directly or indirectly from Healthcare and allied sectors. Hence, the undercurrents of the entire pharma/healthcare value chain will have a bearing on its performance while it MAHF endeavours to achieve its objective.

[Read: Why You Should Be Careful About Investing In NFOs]

---

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014  

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr. Ajit Dayal with an objective of providing value-based information / views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

‘PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

This is not directed for access or use by anyone in a country, especially USA, Canada or the European countries, where such use or access is unlawful or which may subject PersonalFN or its affiliates to any registration or licensing requirement.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, it subsidiaries and its Directors.

Terms and condition on which its offer research report
For the terms and condition for research report click here.

Details of associates

1. Money Simplified Services Limited;
2. PersonalFN Insurance Services India Limited ;
3. Equitymaster Agora Research Private Limited;
4. Common Sense Living Private Limited;
5. Quantum Advisors Private Limited;
6. Quantum Asset Management Company Private Limited;
7. HelpYourNGO Private Limited;
8. HelpYourNGO Foundation;
9. Natural Streets for Performing Arts Foundation;
10. Primary Real Estate Advisors Private Limited;
11. Rahul Goel;
12. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
 

1. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company, except QIS receives fees for providing research to Quantum Equity Fund of Fund (QEFoF) which is Fund of Fund scheme managed by QMF and our associates has financial interest in the subject company.
2. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report.
3. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront /annualized & trail), if any, for any Schemes by QMF to QIS is also at arm's length and as per prevailing market practices.
    

Disclosure with regard to receipt of Compensation

1. Neither QIS nor it's Associates have any compensation from the subject Company in the past twelve months.
2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company in the past twelve months.
3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company in the past twelve months.
4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months, except that QIS had receive fees for services under sponsorship agreement from Franklin Templeton Asset Management India Pvt. Ltd.
5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report
    

General disclosure

1. The Research Analyst has not served as an officer, director or employee of the subject Company.
2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.
    

Subject Company means Mutual Fund Schemes

Quantum Information Services Pvt. Ltd. 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021. Tel: +91 22 6136 1200
Website : www.personalfn.com CIN: U65990MH1989PTC054667

 

© Quanutm Information Services Pvt. Ltd. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of PersonalFN is strictly prohibited and shall be deemed to be copyright infringement.

Disclaimer: Quantum Information Services Pvt. Limited (PersonalFN) is not providing any investment advice through this service and, does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities. All content and information is provided on an 'As Is' basis by PersonalFN. Information herein is believed to be reliable but PersonalFN does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. PersonalFN and its subsidiaries / affiliates / sponsors or employees, personnel, directors will not be responsible for any direct / indirect loss or liability incurred by the user as a consequence of him or any other person on his behalf taking any investment decisions based on the contents and information provided herein. This is not a specific advisory service to meet the requirements of a specific client. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. All intellectual property rights emerging from this newsletter are and shall remain with PersonalFN. This is for your personal use and you shall not resell, copy, or redistribute this newsletter or any part of it, or use it for any commercial purpose. The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing PersonalFN's content and website, you agree to our Terms and Conditions of Use, available here.

Quantum Information Services Pvt. Ltd. Regd. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021. Email: info@personalfn.com CIN: U65990MH1989PTC054667

SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013

Add Comments